Evolus Statistics
Total Valuation
Evolus has a market cap or net worth of $660.03 million. The enterprise value is $703.06 million.
Important Dates
The next estimated earnings date is Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Evolus has 63.59 million shares outstanding. The number of shares has increased by 8.96% in one year.
| Current Share Class | 63.59M |
| Shares Outstanding | 63.59M |
| Shares Change (YoY) | +8.96% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 2.17% |
| Owned by Institutions (%) | 74.69% |
| Float | 56.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.42 |
| Forward PS | 1.84 |
| PB Ratio | 119.36 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.40, with a Debt / Equity ratio of 23.54.
| Current Ratio | 2.40 |
| Quick Ratio | 2.14 |
| Debt / Equity | 23.54 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.45 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -8.08% |
| Return on Invested Capital (ROIC) | -14.11% |
| Return on Capital Employed (ROCE) | -16.06% |
| Revenue Per Employee | $802,030 |
| Profits Per Employee | -$151,867 |
| Employee Count | 332 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 7.25 |
Taxes
In the past 12 months, Evolus has paid $664,000 in taxes.
| Income Tax | 664,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.06% in the last 52 weeks. The beta is 0.97, so Evolus's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -10.06% |
| 50-Day Moving Average | 12.72 |
| 200-Day Moving Average | 13.52 |
| Relative Strength Index (RSI) | 41.23 |
| Average Volume (20 Days) | 1,005,028 |
Short Selling Information
The latest short interest is 7.15 million, so 11.25% of the outstanding shares have been sold short.
| Short Interest | 7.15M |
| Short Previous Month | 7.05M |
| Short % of Shares Out | 11.25% |
| Short % of Float | 12.57% |
| Short Ratio (days to cover) | 9.84 |
Income Statement
In the last 12 months, Evolus had revenue of $266.27 million and -$50.42 million in losses. Loss per share was -$0.81.
| Revenue | 266.27M |
| Gross Profit | 182.30M |
| Operating Income | -27.24M |
| Pretax Income | -52.99M |
| Net Income | -50.42M |
| EBITDA | -21.94M |
| EBIT | -27.24M |
| Loss Per Share | -$0.81 |
Full Income StatementBalance Sheet
The company has $86.95 million in cash and $129.98 million in debt, giving a net cash position of -$43.03 million or -$0.68 per share.
| Cash & Cash Equivalents | 86.95M |
| Total Debt | 129.98M |
| Net Cash | -43.03M |
| Net Cash Per Share | -$0.68 |
| Equity (Book Value) | 5.52M |
| Book Value Per Share | 0.09 |
| Working Capital | 88.38M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.00 million and capital expenditures -$1.47 million, giving a free cash flow of -$19.47 million.
| Operating Cash Flow | -18.00M |
| Capital Expenditures | -1.47M |
| Free Cash Flow | -19.47M |
| FCF Per Share | -$0.31 |
Full Cash Flow StatementMargins
Gross margin is 68.46%, with operating and profit margins of -10.23% and -18.94%.
| Gross Margin | 68.46% |
| Operating Margin | -10.23% |
| Pretax Margin | -18.69% |
| Profit Margin | -18.94% |
| EBITDA Margin | -8.24% |
| EBIT Margin | -10.23% |
| FCF Margin | n/a |
Dividends & Yields
Evolus does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.96% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.64% |
| FCF Yield | -2.95% |
Analyst Forecast
The average price target for Evolus is $23.75, which is 129.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $23.75 |
| Price Target Difference | 129.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 26.37% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Evolus has an Altman Z-Score of -0.27 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.27 |
| Piotroski F-Score | 4 |